Smith M L, Yeleswarapu L, Scalamogna P, Locker J, Lombardi B
Department of Pathology, School of Medicine, University of Pittsburgh, PA 15261.
Carcinogenesis. 1993 Mar;14(3):503-10. doi: 10.1093/carcin/14.3.503.
Analyses were performed on livers and hepatocellular carcinomas from male Fischer 344 rats fed a choline-devoid diet, to assess whether they carried alterations of the p53 tumor suppressor gene. The analyses consisted of immunoperoxidase staining of tissue sections with monoclonal antibodies to p53, Western blotting and cDNA sequencing. Immunostaining revealed the presence of mutant p53 proteins in 22/27 tumors analyzed and immunoblotting in 18/20. Immunochemical evidence was obtained that occurrence of the mutations precedes tumor development. cDNA sequencing was performed on 11 hepatocellular carcinomas that expressed mutant p53 gene proteins. Seven were found to contain point mutations within the 120-290 codon region of the gene, and one a microdeletion in the same region. No mutational hot spot was observed. It is concluded that mutations within the p53 gene, along with a c-myc gene amplification previously detected in these tumors, most likely contribute to the neoplastic transformation of liver cells in this nutritional model of hepatocarcinogenesis. The results are discussed also in view of recent literature on the presence of p53 mutations in human hepatocellular carcinomas.
对喂食缺乏胆碱饮食的雄性Fischer 344大鼠的肝脏和肝细胞癌进行了分析,以评估它们是否携带p53肿瘤抑制基因的改变。分析包括用抗p53单克隆抗体对组织切片进行免疫过氧化物酶染色、蛋白质印迹法和cDNA测序。免疫染色显示,在分析的27个肿瘤中有22个存在突变型p53蛋白,蛋白质印迹法检测在20个中有18个存在。获得的免疫化学证据表明,突变的发生先于肿瘤的发展。对11个表达突变型p53基因蛋白的肝细胞癌进行了cDNA测序。发现7个在该基因的120 - 290密码子区域内含有点突变,1个在同一区域存在微缺失。未观察到突变热点。得出的结论是,p53基因内的突变,连同先前在这些肿瘤中检测到的c-myc基因扩增,很可能促成了这种肝癌发生营养模型中肝细胞的肿瘤转化。还结合最近关于人类肝细胞癌中存在p53突变的文献对结果进行了讨论。